PHARVARIS N.V. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.5 USD | -5.60% |
|
-4.50% | -26.93% |
| 05-09 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
| 05-08 | Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
45698e38a833356dc.sFRYpaxENocd5VX5wFnRFPpCeOjXuLyCruWZJZUNLNQ.3iAzlZ4jcfVfgiOciw-lQ5kyQIzvwMnVmrbQcKxOHKLhOh_hxSVi0mjSYQ~31d13a4a186fac36aa31e70fa0acd216
